AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06184165 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Personalized rTMS
Description: 5 personalized targets accessible to TMS (at less than 3.5 cm distance from the scalp or the coil's hot spot) are placed in the hyper-perfused premotor regions.~The patient is installed on the robotic device. The technician puts a neuro-navigation tracker on the subject's forehead and proceeds to the co-registration. The motor threshold is defined, and stimulator output's intensity is adjusted accordingly (120%) The robotic system ensures that the actual stimulation is performed according to the personalized protocol. This adequacy will be evaluated secondarily based on the recordings of the coil positions during each
Study NCT06318559 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 3D Robot-assisted laparoscopic radical prostatectomy and pelvic lymphadenectomy
Description: The operation is performed using the Da Vinci HD robotic system which allows the use of laparoscopic instruments, with greater mobility and the possibility of easier and more precise control of movements in three dimensions. Furthermore, the system allows the surgeon a three-dimensional view of the operating field. The surgery is performed under general anesthesia. Six or more trocars are positioned, into which the instruments operated by the robot or directly by the surgical assistants are inserted.~Then a radical prostatectomy is performed.
Study NCT06125626 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotical
Description: A daily sachet of Lacticaseibacillus rhamnosus LR04 + Streptococcus thermophilus FP4 + Bifidobacterium breve BR03 will be given to this group
Study NCT06125626 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A daily sachet of placebo will be given to this groups
Study NCT05763472 — intervention group
Intervention type: GENETIC
Intervention: Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
Description: Next-generation sequencing (NGS) analysis with TruSight Oncology 500 (TSO 500) is performed on tumor samples from breast and ovarian cancer of the enrolled patients.
Study NCT06038968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate 25 MG/ML
Description: Methotrexate is a folate derivative that inhibits several enzymes responsible for nucleotide synthesis. This inhibition leads to suppression of inflammation as well as prevention of cell division.
Study NCT06038968 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: parsplana vitrectomy
Description: Pars plana vitrectomy (PPV) is a technique in vitreoretinal surgery that enables access to the posterior segment for treating tractional retinal detachment in advanced proliferative diabetic retinopathy, in a controlled, closed system.
Study NCT06038968 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: parsplana vitrectomy
Description: Pars plana vitrectomy (PPV) is a technique in vitreoretinal surgery that enables access to the posterior segment for treating tractional retinal detachment in advanced proliferative diabetic retinopathy, in a controlled, closed system.
Study NCT06237361 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Description: participants underwent a 12-week intervention involving three Pilates sessions per week. The Pilates exercises comprised warm-up activities, Pilates routines, and cool-down exercises.
Study NCT06237361 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: traditional physical therapy program
Description: The program included a variety of exercises such as range of motion exercises, aerobic exercises, resistance exercises, scar management, occupational therapy, and hand therapy.
Study NCT05026892 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention, only collection of data
Study NCT06127108 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Panbio™
Description: The Panbio™ COVID-19/Flu A\&B Panel is a visual lateral flow in vitro immunoassay for the qualitative detection of the nucleocapsid protein antigen to SARS-CoV-2, Influenza A, and Influenza B in anterior nasal swab samples from individuals with symptoms and suspected of COVID-19 or Flu infection by their healthcare provider.
Study NCT06140550 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Drug balloon dilated
Description: Through the expansion after the balloon is in place,Release drugs on the surface of the balloon and improve the blood perfusion of nerve vessels to treat stenosis
Study NCT06140550 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: balloon dilated
Description: Through the expansion after the balloon is in place, improve the blood perfusion of nerve vessels to treat stenosis.
Study NCT05900466 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: 500 mg Metformin ER tablets once daily in the morning for 8 weeks
Study NCT06366854 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Personalised fluid and haemodynamic resuscitation
Description: individualised resuscitation
Study NCT05900466 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching tablets once daily in the morning for 8 weeks
Study NCT04565652 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Device Wearers
Description: The intervention arm will wear the LOIS ICD Smartband during routine ICD defibrillation following elective ICD implant.
Study NCT05443698 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Transvaginal ultrasound
Description: Adult women in the U.S. who are eligible for the ultrasound trial on the basis of the inclusion/exclusion criteria will complete an at home transvaginal ultrasound guided by real-time remote supervision from a qualified and specially trained ultrasound technologist.
Study NCT03894306 — intervention group
Intervention type: OTHER
Intervention: Medication lock box
Description: given a lock box and instructed on how to use the device.
Study NCT03894306 — intervention group
Intervention type: OTHER
Intervention: medication lock bag
Description: given a lock bag and instructed on how to use the device.
Study NCT03894306 — intervention group
Intervention type: OTHER
Intervention: brief counseling
Description: After completing the per-intervention survey, a research assistant or investigator will perform brief counseling, including educational handouts and information on safe medication storage
Study NCT04882826 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Sildenafil film-coated tablet 100 mg
Description: Sildenafil is manufactured by Pharmtechnology LLC, Belarus. Each tablet contains 100 mg of sildenafil.
Study NCT04882826 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Viagra® film-coated tablet 100 mg
Description: Viagra® is manufactured by Fareva Amboise, France. Each tablet contains 100 mg of sildenafil.
Study NCT04951479 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gel-Bead embolization
Description: OptiSphere is FDA approved for the embolization of hypervascular tumors. The product is crosslinked with glutaraldehyde, which improves the mechanical strength of the spheres and provides controlled degradation after implant. The spherical shape provides smooth embolic delivery and even, predictable distribution. In this study the Optispheres will be used for Geniculate artery embolization (GAE) which is a minimally-invasive procedure that has historically been performed for treatment of patients with recurrent knee hemarthrosis. Embolization is a procedure in which material is used to block small blood vessels. Angiogenesis, or growth of new vessels, has been implicated in the initiation and maintenance of joint inflammation. GAE has been applied to patients with moderate osteoarthritis-related pain refractory to maximal medical management with preliminary studies demonstrating a reduction in patient pain.
Study NCT05492799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AX 250
Description: biweekly infusion by intracerebroventricular (ICV) infusion
Study NCT04662073 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camostat
Description: 200 mg (2 x 100 mg tablet) administered orally four times daily (800 mg total daily dose).
Study NCT04662073 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match camostat administered orally four times daily
Study NCT04844203 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Polygraphy with surface electrodes
Description: Patients referred for ENMG to the Clinical Physiology Department and complaining of postural unsteadiness will undergo a polygraphy recording using surface electrodes (Natus Medical Incorporated), performed at the end of ENMG
Study NCT05761678 — intervention group
Intervention type: OTHER
Intervention: Questionnaire quality of life
Description: Quantitative - Validated online self-questionnaires scientifically to assess quality of life and support perceived social. Items created for the study concerning socio-demographic characteristics and satisfaction of health services concerning the accompaniment of the transidentity.~Qualitative - Semi-structured interviews based on a guide maintenance.
Study NCT04757688 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Cardiac radioablation (CRA)
Description: CRA to 25 Gy in 1 fraction
Study NCT04773561 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Corneal tomography, optical coherence tomography and optical coherence tomography angiography
Description: Ocular investigations were performed in one time during 30-36 weeks of gestational age. Due to avoidance of diurnal variation, all examinations were done between 10 am - 12 pm.
Study NCT04693091 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Senti V1.0 Device
Description: This device class I, CE marked garment, with a similar form to a T-Shirt, embedded with ten sensor modules encased in silicone; the device comes with a charging stand in the form of a clothes hanger. Depending on the outcome of this feasibility study, the device may, in the future, form part of a class IIb medical device system, when accompanied by cloud-based software to listen to both current and historically recorded breath sounds for each Senti patient. The Senti Version One device will be labelled clearly to indicate the device version, on the inside of the garment, conforming to the MDR.~The garment itself will be made from textile composite, including cotton, elastase, micromodel, spandex, and polyester. All other components (including electronic and other plastic components) will be entirely encased in medical-grade silicone.
Study NCT04972097 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Irreversible Electroporation
Description: IRE of the prostate is typically performed with the subject in the lithotomy position, with 2-6 monopolar probes placed through the perineum using a brachytherapy grid and ultrasound or CT guidance. IRE supplies the targeted tissue with high voltage (2-3 kV) direct current pulses lasting up to 100 microseconds through the electrode probes.
Study NCT05535790 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Naturalistic LED light
Description: Naturalistic LED light (bright light therapy) which affects Melanopic Equivalent Daylight Illuminance.
Study NCT05535790 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Standard/traditional lighting
Description: Standard/tradtional lighting environment with fluorescent tubes
Study NCT05455645 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: targeted intrinsic foot muscle exercises
Description: 4 targeted intrinsic foot muscle exercises
Study NCT04773561 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Corneal tomography, optical coherence tomography and optical coherence tomography angiography
Description: Ocular investigations were performed in one time during 30-36 weeks of gestational age. Due to avoidance of diurnal variation, all examinations were done between 10 am - 12 pm.
Study NCT06687226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Reconstitutable food powder
Description: During the intervention week, participants will be asked take one dose of a reconstitutable food powder provided in a ziplock bag. This powder will be a mix of Gatorade Zero Powder (1 serving) and 1 serving of commercially available powders of either one or all of the following: camu camu, kelp or maqui. The powder mix in the bag will be added to water and drunk by the participant as soon as possible after having a bowel movement (baseline stool sample). Food powders are sourced from reputable companies and are safe for consumption (Gatorade is a wellrecognized brand and available in grocery stores nationally, Navitas Organics provides certified organic, third-party tested plant food powders with fairtrade certification).
Study NCT06008769 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 12 Week Manualized Cognitive-Behavioral Therapy Intervention
Description: The manualized intervention, Cognitive Behavioral Therapy for Opioid Use Disorder, was co-written and developed by the study PI, Dr. Lent (see Appendix). The manual consists of one module (Module 0) on assessment and 12 modules of CBT. This study will focus on delivery of Modules 1-12 that focus on several tenets of CBT, including skill development (cognitive restructuring, refusal skills, problem-solving, coping strategies), functional analysis (triggers, reinforcement) and utilizing the cognitive model.
Study NCT06699537 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: probiotic product
Description: During the study, subjects take one sachet of Lactobacillus rhamnosus LRa05 daily. Evaluation is conducted by monitoring the subjects' nasal symptoms and gut microbiota before and after the intervention.
Study NCT06699537 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: During the study, subjects in the control group take one sachet of maltodextrin daily with 3.0g. Evaluation is conducted by monitoring the subjects' nasal symptoms and gut microbiota before and after the 8-week trial.
Study NCT05750615 — intervention group
Intervention type: OTHER
Intervention: Uncertain what intervention will be co-created
Description: Uncertain what intervention will be co-created
Study NCT06699485 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low carb diet
Description: Low-carbohydrate diet contains (\<26% carbohydrates) or less than 130 g/d
Study NCT05460910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability exercises with treadmill
Description: swiss ball use patient is lying in supine position with 15 repitations and 3 sets.
Study NCT05460910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability exercise without treadmill
Description: technique used to improve stability
Study NCT04536922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Days -7 and -6: Cyclophosphamide 60 mg/kg/day x 2 days IV in 250 mL D5W infused simultaneously with mesna 15 mg/kg /day over 1 hour x 2 days.
Study NCT04536922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Days -7 to -3: Fludarabine 25 mg /m2/day IVPB daily over 30 minutes for 5 days.
Study NCT04536922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Description: Aldesleukin 720,000 IU/kg IV (based on total body weight) over 15 minutes approximately every 8 hours beginning within 24 hours of cell infusion and continuing for up to 4 days (maximum 10 doses).
Study NCT04536922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (KEYTRUDA(R))
Description: Pembrolizumab 2 mg /kg IV over approximately 30 minutes on Days -2, 21, 42, and 63.
Study NCT04536922 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Individual Patient TCR-Transduced PBL
Description: Day 0: Cells will be infused at a dose not to exceed 1.5e11 in 400 mL intravenously on the Patient Care Unit over 20-30 minutes (2-4 days after the last dose of fludarabine).
Study NCT04003480 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FRAME
Description: External support for vein grafts in peripheral bypass surgery
Study NCT05258084 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sexual minority awareness training
Description: sexual minority awareness training is planned as 4 interviews (1 interview per week) for a total of 4 hours. Gender and sexuality-related terminologies and concepts will be discussed in the 1st meeting. Expression of sexual identity and gender transition processes will be examined in the 2nd meeting. In the 3rd meeting, the determining factors in the inadequate utilization of health services by LGBT individuals will be discussed. In the 4th meeting, what can be done to create a safe and health-friendly environment for LGBT individuals and healthcare professionals will be discussed.
Study NCT06252896 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: INSTRUMENTAL-ASSISTED SOFT TISSUE MOBILIZATION TECHNIQUE
Description: After all evaluations were made, IASTM was applied to the individuals in the intervention group for five minutes each, for a total of 20 minutes, on the quadriceps and hamstring muscles of both extremities, respectively.
Study NCT06252896 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: NO INTERVENTION
Description: The control group waited for 30 minutes after the initial measurements and all measurements were repeated.
Study NCT05285475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and Water Intake
Description: The exercise protocol for this group will be abdominals, pelvic stretching and kegels exercises (PFM) for three days/week lasting about 30 minutes with approximately 1600-1800ml (8-10 glasses) intake of water for 8 weeks (two consecutive menstrual cycles)~Exercises include:~Piriformis stretching (5 repetitions×20 seconds) Adductor stretching (5 repetitions×20 seconds) Sit-ups (10 repetitions×3 sets) Bridging (10 repetitions×3 sets) Kegels exercises (10 repetions×3 sets) Pelvic elevation (10 repetitions×3 sets) Pelvic rotation (10 repetitions×3 sets) Cobra pose (5 repetitions×20 seconds)
Study NCT05973383 — intervention group
Intervention type: BEHAVIORAL
Intervention: LongLife Active- Basic
Description: The digital service LongLife Active with three core subjects:~1) a Healthy diet, 2) Physical activity, and 3) Mental balance. The service includes tracking and self-monitoring of behaviors, goal setting, action planning, feedback and digital rewards, an AI chat, a database with food recipes, a database with exercises, inspiration, and skills training webinars.
Study NCT05973383 — intervention group
Intervention type: BEHAVIORAL
Intervention: LongLife Active- Standard
Description: The digital service LongLife Active with three core subjects:~1) a Healthy diet, 2) Physical activity, and 3) Mental balance. The service includes tracking and self-monitoring of behaviors, goal setting, action planning, feedback and digital rewards, an AI chat, a database with food recipes, a database with exercises, inspiration, and skills training webinars.~Users with the membership Standard are also offered a community with social support.
Study NCT05973383 — intervention group
Intervention type: BEHAVIORAL
Intervention: LongLife Active- Premium
Description: The digital service LongLife Active with three core subjects:~1) a Healthy diet, 2) Physical activity, and 3) Mental balance. The service includes tracking and self-monitoring of behaviors, goal setting, action planning, feedback and digital rewards, an AI chat, a database with food recipes, a database with exercises, inspiration, and skills training webinars.~Users with the membership Premium are also offered a community with social support plus private on-line health consultations. The number of private health consultations is 3 for a 3 months subscription, 4 for a 6 months subscription, and 6 for a 12 months subscription.
Study NCT05302856 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood test (CMV IGG, Anti sperm antibody, Testosterone levels)
Description: Peripheric blood extraction
Study NCT04408417 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prototype child safety seat with tension indicator lights
Description: The prototype child safety seat is a convertible rear-facing seat with a harness system that includes tension indicator lights.
Study NCT04408417 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control child safety seat
Description: The control child safety seat is a convertible rear-facing seat without tension indicator lights.
Study NCT06155734 — intervention group
Intervention type: DRUG
Intervention: Fluorescence guided identification using indocyanine green
Description: During minimally invasive surgery using intravenous administration of indocyanine green (ICG) near-infrared fluorescence imaging will be applied to identify and treat paragangliomas
Study NCT00670176 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: REHAB (Pre- and postoperative cardiopulmonary rehabilitation)
Study NCT04904796 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CIMT
Description: CIMT : Constraint-Induced Movement Therapy (CIMT) is a deviation from traditional treatments, used to treat hemiplegia. Its aim is to stimulate the functional use of the affected limb and reverse the process developmental is disregard. In this method, the unaffected or less affected limb is restrained, so the person has to use the affected limb.
Study NCT04904796 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CIMT
Description: CIMT : Constraint-Induced Movement Therapy (CIMT) is a deviation from traditional treatments, used to treat hemiplegia. Its aim is to stimulate the functional use of the affected limb and reverse the process developmental is disregard. In this method, the unaffected or less affected limb is restrained, so the person has to use the affected limb.